Empowers clinicians who seek evidence‑based insights by delivering AI‑summarized medical research at the point of care.
You can scroll over the chart's area to move in time and tap to see a specific date.
Highest Bid
$ 260.80
Lowest Offer
$ 188.50
Last Trade
$ 234.00
Live Orders
1,298
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
OpenEvidence delivers an AI-driven platform that helps healthcare professionals effortlessly explore and understand medical research. It synthesizes peer-reviewed clinical studies and multimedia into digestible insights that support informed decision making at the point of care. The platform seamlessly integrates evidence-based content into clinicians’ workflows to enhance patient outcomes.
OpenEvidence Funding
Sign up to gain insights into OpenEvidence funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series C | Oct 20, 2025 | 75M | ||
| Series C | Oct 20, 2025 | 125M | ||
| Series Preferred | Jul 15, 2025 | 30M | ||
| Series Preferred | Jul 15, 2025 | 125M | ||
| Series D | Feb 19, 2025 | 75M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
OpenEvidence Management Team
Investors
Greycroft
Coatue
Sequoia Capital
Kleiner Perkins Caufield & Byers
Thrive Capital Partners
Google Ventures
OpenEvidence Valuations & Financials
View real-time NPM data on OpenEvidence stock including daily OpenEvidence stock price estimates, valuation history, and historical share price information. Access OpenEvidence financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track OpenEvidence pricing across six independent market signals. Looking for private company due diligence data sources on OpenEvidence? Get in touch to learn more.
Similar Companies
like OpenEvidence
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Benchling
Healthcare & Life Sciences
Cloud based platform for research and development in biotechnology.
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
FAQ
We have answers
OpenEvidence stock does not trade on public stock exchanges. OpenEvidence stock is considered a private security and you need to be an accredited investor to trade shares. To invest in OpenEvidence stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
OpenEvidence Stock does not trade on public stock exchanges. In order to sell OpenEvidence shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nasdaq Private Market estimates that OpenEvidence price per share was $521.89 as of July 13, 2026. This OpenEvidence share value estimate (known as the NPM price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With NPM Data and Intelligence premium for investors, you can get visibility into the OpenEvidence share price today and the factors driving OpenEvidence valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
There is no ticker symbol for OpenEvidence stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell OpenEvidence stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in OpenEvidence stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
OpenEvidence is a private company and has not had an IPO. There is currently no OpenEvidence IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to OpenEvidence IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
